Exenatide
Showing 1 - 25 of 425
Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))
Not yet recruiting
- Type 2 Diabetes
- NPM-119 (exenatide implant)
- Bydureon BCise (exenatide extended release)
- (no location specified)
Jan 29, 2023
Gestational Diabetes Trial (Exenatide)
Not yet recruiting
- Gestational Diabetes
- Exenatide
- (no location specified)
Jul 28, 2022
Parkinson Disease Trial in Stockholm (Exenatide, Placebo)
Active, not recruiting
- Parkinson Disease
- Exenatide
- Placebo
-
Stockholm, SwedenAcademic Specialist Center, Center for Neurology, SLSO
Sep 12, 2022
Smoking Cessation, Weight Gain Trial in Houston (Exenatide 2 milligram (mg) Injection, Placebo, Nicotine patch)
Not yet recruiting
- Smoking Cessation
- Weight Gain
- Exenatide 2 milligram (mg) Injection
- +3 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
Nov 2, 2022
Parkinson's Disease Trial in Gainesville (Exenatide)
Completed
- Parkinson's Disease
- Exenatide
-
Gainesville, FloridaLaboratory for Rehabilitation Neuroscience
Sep 14, 2022
Cocaine Use Disorder Trial in Houston (Exenatide 2 mg [Bydureon], Drug Counseling)
Completed
- Cocaine Use Disorder
- Exenatide 2 mg [Bydureon]
- Drug Counseling
-
Houston, TexasUTHealth Behavioral and Biomedical Sciences Building
May 31, 2022
Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Dapagliflozin
- +2 more
-
San Antonio, TexasUniversity of Texas Health Science Center
Sep 12, 2022
A Pan-European Post-Authorisation Safety Study: Risk of
Not yet recruiting
- Pancreatic Cancer
- Exenatide
- Non-GLP-1 RA based glucose lowering drugs
- (no location specified)
Dec 21, 2022
Parkinson's Disease Trial in London (Exenatide extended release 2mg (Bydureon))
Active, not recruiting
- Parkinson's Disease
- Exenatide extended release 2mg (Bydureon)
-
London, United KingdomUniversity College London Hospital
May 18, 2022
Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)
Terminated
- Type 2 Diabetes
- Exenatide Injection
- Saline injection
-
Lancaster, PennsylvaniaAmish Research Clinic
Mar 6, 2023
Euglycemia, Hypoglycemia, Hyperglycemia Trial in Philadelphia (Exenatide 0.27 ng/kg/min, Exenatide 0.41 ng/kg/min, Placebo)
Completed
- Euglycemia
- +2 more
- Exenatide 0.27 ng/kg/min
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 21, 2021
Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Placebo
- +3 more
-
San Antonio, TexasUniversity Health System Texas Diabetic Institute
Apr 28, 2022
Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)
Completed
- Pre-diabetes
- Type 2 Diabetes
- Exenatide
- +2 more
-
Philadelphia, Pennsylvania
- +2 more
May 16, 2022
Alcohol Use Disorder Trial in Boston (Exenatide, Sham injection)
Terminated
- Alcohol Use Disorder
- Exenatide
- Sham injection
-
Boston, MassachusettsBoston University Psychiatry Research Center, Clinical Studies U
Jan 14, 2022
Steatosis, Liver, Type2 Diabetes Trial in Wien (Exenatide, Exenatide matching Placebo, Dapagliflozin)
Completed
- Steatosis, Liver
- Type2 Diabetes
- Exenatide
- +2 more
-
Wien, AustriaAbt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Med
Apr 8, 2022
Schizophrenia, Schizoaffective Disorder Trial in Worcester (Exenatide, Placebo)
Completed
- Schizophrenia
- Schizoaffective Disorder
- Exenatide
- Placebo
-
Worcester, MassachusettsUMass Medical School
Jan 4, 2022
Diabetes Trial in San Antonio (metformin\pioglitazone\exenatide, metformin, glyburide and glargine)
Active, not recruiting
- Diabetes
- metformin\pioglitazone\exenatide
- metformin, glyburide and glargine
-
San Antonio, TexasTexas Diabetes Institute
Mar 8, 2022
Type 1 Diabetes Trial in Bronx (Exenatide, Rapid and long acting insulin, long acting insulin + rapid acting + 1.25 mcg
Completed
- Type 1 Diabetes
- Exenatide
- +2 more
-
Bronx, New YorkAlbert Einstein CRC- West Campus
Jul 13, 2021
Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)
Not yet recruiting
- Diabetes Mellitus, Type 1
- +3 more
- Anti-Thymocyte Globulin (ATG)
- +7 more
-
Miami, FloridaDiabetes Research Institute, University of Miami Miller School o
Feb 23, 2022
Endogenous Hyperinsulinism Trial in Basel (Exenatide, 0.9% saline solution)
Recruiting
- Endogenous Hyperinsulinism
- Exenatide
- 0.9% saline solution
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Nuclear Medicine
May 31, 2021
Dysglycemia, Cognitive Deficit Trial in Parma (Exenatide, )
Active, not recruiting
- Dysglycemia
- Cognitive Deficit
- Exenatide
- placebo
-
Parma, Italy
- +1 more
Aug 10, 2021
Obesity Trial in Boston (Exenatide, Placebo, Dietary counseling)
Completed
- Obesity
- Exenatide
- +2 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jun 18, 2021
Diabetes Associated With Genetic Syndrome, Wolfram Syndrome Trial (Exenatide)
Withdrawn
- Diabetes Mellitus Associated With Genetic Syndrome
- Wolfram Syndrome
- Exenatide
- (no location specified)
Mar 14, 2022
Diabetes, Type 2 Trial in Shavano Park (Exenatide 2 MG, Dapagliflozin 10 MG)
Completed
- Diabetes Mellitus, Type 2
- Exenatide 2 MG
- Dapagliflozin 10 MG
-
Shavano Park, TexasConsano Clinical Research, LLC
Aug 24, 2021